Riskpilot← Back to searchSign inGet full accessBALTOPPEN BIO ApS
APSDissolvedCVR 34478228Baltorpvej 20Motion picture projection activities · NACE 5914Est. 201217 employees
Revenue 2023
DKK 3K
-112% vs 2022
EBITDA margin
100.0%
+111% vs 2022
Equity ratio
76.7%
Financial strength
Net profit 2023
DKK 12K
+225% vs 2022
| Revenue | DKK 3K | -112% |
| EBITDA | DKK 3K | +111% |
| Net profit | DKK 12K | +225% |
| Total assets | DKK 310K | +4% |
| Equity | DKK 238K | +5% |
| Employees | 17 | — |
Legal name
BALTOPPEN BIO ApS
CVR number
34478228
Legal form
Anpartsselskab
NACE code
5914 · Motion picture projection activities
Founded
5. april 2012
Share capital
DKK 80.000
Employees
17 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller to bestyrelsesmedlemmer i forening.
Address
Baltorpvej 20
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | 1.223 | 1.317 | 1.374 | 1.528 | 800 | 399 | -24 | 3 |
| Staff expenses | -1.559 | -1.327 | -1.029 | -1.194 | -1.143 | -1.203 | -1.305 | -1.378 | -962 | -199 | -1 | -0 |
| EBITDA | 145 | 27 | 29 | 272 | 80 | 115 | 69 | 150 | -162 | 200 | -25 | 3 |
| Depreciation & amort. | 76 | -92 | -95 | -94 | -68 | -50 | -39 | -32 | -20 | -0 | -0 | -0 |
| EBIT | 69 | -66 | -67 | 179 | 12 | 64 | 30 | 118 | -182 | 200 | -25 | 3 |
| Net financials | 6 | 9 | -0 | -0 | 0 | -0 | -0 | -2 | -1 | 10 | 12 | 13 |
| Profit before tax | 76 | -57 | -67 | 179 | 12 | 64 | 30 | 116 | -183 | 209 | -13 | 16 |
| Tax | 20 | 28 | 28 | 43 | 3 | 14 | 7 | 25 | -41 | 46 | -3 | 3 |
| Net profit | 55 | -85 | -95 | 136 | 9 | 50 | 23 | 90 | -142 | 163 | -10 | 12 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.099 | 919 | 866 | 851 | 721 | 738 | 704 | 735 | 382 | 316 | 297 | 310 |
| Equity | 135 | 1 | -94 | 42 | 51 | 101 | 124 | 214 | 72 | 235 | 225 | 238 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 958 | 918 | 961 | 809 | 671 | 637 | 580 | 521 | 310 | 81 | 72 | 72 |
| Total debt | 958 | 918 | 961 | 809 | 671 | 637 | 580 | 521 | 310 | 81 | 72 | 72 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122023
Equity ratio
76.7%
This company
38.2%
Market median
+101% vs market
20122023
Return on equity
5.2%
This company
18.4%
Market median
-72% vs market
20122023
Net profit margin
446.1%
This company
8.1%
Market median
+5407% vs market
20122023
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20122023
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20122023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-04-05 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JB Management | Management | 2014 | — | — |
EM Management | Management | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KF | Chairman | 2013 | — | — |
| Chairman | 2012 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Jan B Holding ApS | Company | 100.0% | 100.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BALTOPPEN BIO ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Bøye Thomsen | Management | 0 companies |
| Emil Mark Nørholm | Management | 0 companies |
| Kim Foss | Chairman | 0 companies |
| Christian Kirk Zøllner | Chairman | 0 companies |